APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceftazidime Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ceftazidime Injection Industry Growth and Trends Forecast to 2032

2 January 2026102 pages

Choose your research edition.

Industry ResearchCeftazidime Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftazidime Injection Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Ceftazidime Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftazidime Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftazidime Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ceftazidime Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ceftazidime Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ceftazidime Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceftazidime Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ceftazidime Injection include Allergan, B Braun, Sagent, Teligent, WG Critical Care, Anhui Welman, GSK, Guangzhou Baiyunshan Tianxin Pharmaceutical and Hainan Hailing Chemipharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ceftazidime Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceftazidime Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceftazidime Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceftazidime Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceftazidime Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceftazidime Injection Market by Company

Allergan

B Braun

Sagent

Teligent

WG Critical Care

Anhui Welman

GSK

Guangzhou Baiyunshan Tianxin Pharmaceutical

Hainan Hailing Chemipharma

Pfizer

CSPC Zhongnuo Pharmaceutical

Ceftazidime Injection Segment by Type

6g/vial

2g/vial

1g/vial

Ceftazidime Injection Segment by Application

Recovery Center

Hospital

Clinics

Ceftazidime Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftazidime Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftazidime Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftazidime Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceftazidime Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceftazidime Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 6g/vial Table 2. Major Company of 2g/vial Table 3. Major Company of 1g/vial Table 4. Global Ceftazidime Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ceftazidime Injection Sales by Type (2021-2026) & (W Units) Table 6. Global Ceftazidime Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Ceftazidime Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Ceftazidime Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Ceftazidime Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Ceftazidime Injection Sales by Type (2027-2032) & (W Units) Table 11. Global Ceftazidime Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Ceftazidime Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Ceftazidime Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Ceftazidime Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Ceftazidime Injection Sales by Type (2021-2026) & (W Units) Table 16. North America Ceftazidime Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Ceftazidime Injection Sales by Type (2021-2026) & (W Units) Table 18. Europe Ceftazidime Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Ceftazidime Injection Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Ceftazidime Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Ceftazidime Injection Sales by Type (2021-2026) & (W Units) Table 22. Latin America Ceftazidime Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Ceftazidime Injection Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Ceftazidime Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Ceftazidime Injection Industry Trends Table 26. Ceftazidime Injection Industry Drivers Table 27. Ceftazidime Injection Industry Opportunities and Challenges Table 28. Ceftazidime Injection Industry Restraints Table 29. Global Ceftazidime Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Ceftazidime Injection Revenue Market Share by Company (2021-2026) Table 31. Global Ceftazidime Injection Sales by Company (2021-2026) & (W Units) Table 32. Global Ceftazidime Injection Sales Share by Company (2021-2026) Table 33. Global Ceftazidime Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Ceftazidime Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Ceftazidime Injection Major Company Production Sites and Headquarters Table 36. Global Ceftazidime Injection Company, Product Type & Application Table 37. Global Ceftazidime Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Ceftazidime Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Ceftazidime Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Ceftazidime Injection Sales by Region (2021-2026) & (W Units) Table 42. Global Ceftazidime Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Ceftazidime Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Ceftazidime Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Ceftazidime Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Ceftazidime Injection Sales by Region (2027-2032) & (W Units) Table 47. Global Ceftazidime Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Ceftazidime Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Ceftazidime Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Ceftazidime Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Ceftazidime Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Ceftazidime Injection Sales by Application (2021-2026) & (W Units) Table 53. Global Ceftazidime Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Ceftazidime Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Ceftazidime Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Ceftazidime Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Ceftazidime Injection Sales by Application (2027-2032) & (W Units) Table 58. Global Ceftazidime Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Ceftazidime Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Ceftazidime Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Ceftazidime Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Ceftazidime Injection Sales by Application (2021-2026) & (W Units) Table 63. North America Ceftazidime Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Ceftazidime Injection Sales by Application (2021-2026) & (W Units) Table 65. Europe Ceftazidime Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Ceftazidime Injection Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Ceftazidime Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Ceftazidime Injection Sales by Application (2021-2026) & (W Units) Table 69. Latin America Ceftazidime Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Ceftazidime Injection Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Ceftazidime Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Allergan Company Information Table 73. Allergan Business Overview Table 74. Allergan Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Allergan Ceftazidime Injection Product Portfolio Table 76. Allergan Recent Development Table 77. B Braun Company Information Table 78. B Braun Business Overview Table 79. B Braun Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. B Braun Ceftazidime Injection Product Portfolio Table 81. B Braun Recent Development Table 82. Sagent Company Information Table 83. Sagent Business Overview Table 84. Sagent Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sagent Ceftazidime Injection Product Portfolio Table 86. Sagent Recent Development Table 87. Teligent Company Information Table 88. Teligent Business Overview Table 89. Teligent Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Teligent Ceftazidime Injection Product Portfolio Table 91. Teligent Recent Development Table 92. WG Critical Care Company Information Table 93. WG Critical Care Business Overview Table 94. WG Critical Care Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. WG Critical Care Ceftazidime Injection Product Portfolio Table 96. WG Critical Care Recent Development Table 97. Anhui Welman Company Information Table 98. Anhui Welman Business Overview Table 99. Anhui Welman Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Anhui Welman Ceftazidime Injection Product Portfolio Table 101. Anhui Welman Recent Development Table 102. GSK Company Information Table 103. GSK Business Overview Table 104. GSK Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GSK Ceftazidime Injection Product Portfolio Table 106. GSK Recent Development Table 107. Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information Table 108. Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview Table 109. Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Product Portfolio Table 111. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Development Table 112. Hainan Hailing Chemipharma Company Information Table 113. Hainan Hailing Chemipharma Business Overview Table 114. Hainan Hailing Chemipharma Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hainan Hailing Chemipharma Ceftazidime Injection Product Portfolio Table 116. Hainan Hailing Chemipharma Recent Development Table 117. Pfizer Company Information Table 118. Pfizer Business Overview Table 119. Pfizer Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Pfizer Ceftazidime Injection Product Portfolio Table 121. Pfizer Recent Development Table 122. CSPC Zhongnuo Pharmaceutical Company Information Table 123. CSPC Zhongnuo Pharmaceutical Business Overview Table 124. CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Product Portfolio Table 126. CSPC Zhongnuo Pharmaceutical Recent Development Table 127. North America Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 128. North America Ceftazidime Injection Sales by Country (2021-2026) & (W Units) Table 129. North America Ceftazidime Injection Sales Market Share by Country (2021-2026) Table 130. North America Ceftazidime Injection Sales Forecast by Country (2027-2032) & (W Units) Table 131. North America Ceftazidime Injection Sales Market Share Forecast by Country (2027-2032) Table 132. North America Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Ceftazidime Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Ceftazidime Injection Market Share by Country (2021-2026) Table 135. North America Ceftazidime Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Ceftazidime Injection Market Share Forecast by Country (2027-2032) Table 137. Europe Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 138. Europe Ceftazidime Injection Sales by Country (2021-2026) & (W Units) Table 139. Europe Ceftazidime Injection Sales Market Share by Country (2021-2026) Table 140. Europe Ceftazidime Injection Sales Forecast by Country (2027-2032) & (W Units) Table 141. Europe Ceftazidime Injection Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Ceftazidime Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Ceftazidime Injection Market Share by Country (2021-2026) Table 145. Europe Ceftazidime Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Ceftazidime Injection Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Ceftazidime Injection Sales by Country (2021-2026) & (W Units) Table 149. Asia-Pacific Ceftazidime Injection Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Ceftazidime Injection Sales Forecast by Country (2027-2032) & (W Units) Table 151. Asia-Pacific Ceftazidime Injection Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Ceftazidime Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Ceftazidime Injection Market Share by Country (2021-2026) Table 155. Asia-Pacific Ceftazidime Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Ceftazidime Injection Market Share Forecast by Country (2027-2032) Table 157. Latin America Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 158. Latin America Ceftazidime Injection Sales by Country (2021-2026) & (W Units) Table 159. Latin America Ceftazidime Injection Sales Market Share by Country (2021-2026) Table 160. Latin America Ceftazidime Injection Sales Forecast by Country (2027-2032) & (W Units) Table 161. Latin America Ceftazidime Injection Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Ceftazidime Injection Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Ceftazidime Injection Market Share by Country (2021-2026) Table 165. Latin America Ceftazidime Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Ceftazidime Injection Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Ceftazidime Injection Sales by Country (2021-2026) & (W Units) Table 169. Middle East and Africa Ceftazidime Injection Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Ceftazidime Injection Sales Forecast by Country (2027-2032) & (W Units) Table 171. Middle East and Africa Ceftazidime Injection Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Ceftazidime Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Ceftazidime Injection Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Ceftazidime Injection Market Share by Country (2021-2026) Table 175. Middle East and Africa Ceftazidime Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Ceftazidime Injection Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Ceftazidime Injection Distributors List Table 180. Ceftazidime Injection Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Ceftazidime Injection Image Figure 2. Global Ceftazidime Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftazidime Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceftazidime Injection Sales (2021-2032) & (W Units) Figure 5. 6g/vial Image Figure 6. Global 6g/vial Sales YoY Growth (2021-2032) & (W Units) Figure 7. 2g/vial Image Figure 8. Global 2g/vial Sales YoY Growth (2021-2032) & (W Units) Figure 9. 1g/vial Image Figure 10. Global 1g/vial Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Ceftazidime Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Ceftazidime Injection Market Share by Type 2025 VS 2032 Figure 13. North America Ceftazidime Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Ceftazidime Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Ceftazidime Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Ceftazidime Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Ceftazidime Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Ceftazidime Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Ceftazidime Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Ceftazidime Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Ceftazidime Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Ceftazidime Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Ceftazidime Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Recovery Center Image Figure 26. Global Recovery Center Sales YoY Growth (2021-2032) & (W Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Ceftazidime Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Ceftazidime Injection Market Share by Application 2025 VS 2032 Figure 33. North America Ceftazidime Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Ceftazidime Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Ceftazidime Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Ceftazidime Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Ceftazidime Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Ceftazidime Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Ceftazidime Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Ceftazidime Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Ceftazidime Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Ceftazidime Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Ceftazidime Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Ceftazidime Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Ceftazidime Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Ceftazidime Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ceftazidime Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Ceftazidime Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ceftazidime Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Ceftazidime Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ceftazidime Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Ceftazidime Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ceftazidime Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Ceftazidime Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ceftazidime Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Ceftazidime Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ceftazidime Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Ceftazidime Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ceftazidime Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Ceftazidime Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ceftazidime Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Ceftazidime Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Ceftazidime Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Ceftazidime Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 6g/vial
  • 2g/vial
  • 1g/vial
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • Allergan
  • B Braun
  • Sagent
  • Teligent
  • WG Critical Care
  • Anhui Welman
  • GSK
  • Guangzhou Baiyunshan Tianxin Pharmaceutical
  • Hainan Hailing Chemipharma
  • Pfizer
  • CSPC Zhongnuo Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceftazidime Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceftazidime Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceftazidime Injection Market by Type
  6. 1.3.1 6g/vial
  7. 1.3.2 2g/vial
  8. 1.3.3 1g/vial
  9. 1.4 Global Ceftazidime Injection Market Size by Type
  10. 1.4.1 Global Ceftazidime Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Ceftazidime Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Ceftazidime Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Ceftazidime Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Ceftazidime Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Ceftazidime Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Ceftazidime Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Ceftazidime Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceftazidime Injection Industry Trends
  2. 2.2 Ceftazidime Injection Industry Drivers
  3. 2.3 Ceftazidime Injection Industry Opportunities and Challenges
  4. 2.4 Ceftazidime Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceftazidime Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceftazidime Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Ceftazidime Injection Price (2021-2026)
  4. 3.4 Global Ceftazidime Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceftazidime Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Ceftazidime Injection Company, Product Type & Application
  7. 3.7 Global Ceftazidime Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceftazidime Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceftazidime Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceftazidime Injection Tier 1, Tier 2, and Tier 3
4 Ceftazidime Injection Regional Status and Outlook
  1. 4.1 Global Ceftazidime Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceftazidime Injection Historic Market Size by Region
  3. 4.2.1 Global Ceftazidime Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceftazidime Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceftazidime Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceftazidime Injection Forecasted Market Size by Region
  7. 4.3.1 Global Ceftazidime Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceftazidime Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceftazidime Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceftazidime Injection by Application
  1. 5.1 Ceftazidime Injection Market by Application
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.2 Global Ceftazidime Injection Market Size by Application
  6. 5.2.1 Global Ceftazidime Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ceftazidime Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ceftazidime Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ceftazidime Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ceftazidime Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ceftazidime Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ceftazidime Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ceftazidime Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Ceftazidime Injection Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 B Braun
  8. 6.2.1 B Braun Company Information
  9. 6.2.2 B Braun Business Overview
  10. 6.2.3 B Braun Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 B Braun Ceftazidime Injection Product Portfolio
  12. 6.2.5 B Braun Recent Developments
  13. 6.3 Sagent
  14. 6.3.1 Sagent Company Information
  15. 6.3.2 Sagent Business Overview
  16. 6.3.3 Sagent Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sagent Ceftazidime Injection Product Portfolio
  18. 6.3.5 Sagent Recent Developments
  19. 6.4 Teligent
  20. 6.4.1 Teligent Company Information
  21. 6.4.2 Teligent Business Overview
  22. 6.4.3 Teligent Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teligent Ceftazidime Injection Product Portfolio
  24. 6.4.5 Teligent Recent Developments
  25. 6.5 WG Critical Care
  26. 6.5.1 WG Critical Care Company Information
  27. 6.5.2 WG Critical Care Business Overview
  28. 6.5.3 WG Critical Care Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 WG Critical Care Ceftazidime Injection Product Portfolio
  30. 6.5.5 WG Critical Care Recent Developments
  31. 6.6 Anhui Welman
  32. 6.6.1 Anhui Welman Company Information
  33. 6.6.2 Anhui Welman Business Overview
  34. 6.6.3 Anhui Welman Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Anhui Welman Ceftazidime Injection Product Portfolio
  36. 6.6.5 Anhui Welman Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Ceftazidime Injection Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Guangzhou Baiyunshan Tianxin Pharmaceutical
  44. 6.8.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
  45. 6.8.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview
  46. 6.8.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Product Portfolio
  48. 6.8.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments
  49. 6.9 Hainan Hailing Chemipharma
  50. 6.9.1 Hainan Hailing Chemipharma Company Information
  51. 6.9.2 Hainan Hailing Chemipharma Business Overview
  52. 6.9.3 Hainan Hailing Chemipharma Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hainan Hailing Chemipharma Ceftazidime Injection Product Portfolio
  54. 6.9.5 Hainan Hailing Chemipharma Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Ceftazidime Injection Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 CSPC Zhongnuo Pharmaceutical
  62. 6.11.1 CSPC Zhongnuo Pharmaceutical Company Information
  63. 6.11.2 CSPC Zhongnuo Pharmaceutical Business Overview
  64. 6.11.3 CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Product Portfolio
  66. 6.11.5 CSPC Zhongnuo Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Ceftazidime Injection Sales by Country
  2. 7.1.1 North America Ceftazidime Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceftazidime Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Ceftazidime Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceftazidime Injection Market Size by Country
  6. 7.2.1 North America Ceftazidime Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceftazidime Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceftazidime Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceftazidime Injection Sales by Country
  2. 8.1.1 Europe Ceftazidime Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceftazidime Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceftazidime Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceftazidime Injection Market Size by Country
  6. 8.2.1 Europe Ceftazidime Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceftazidime Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceftazidime Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceftazidime Injection Sales by Country
  2. 9.1.1 Asia-Pacific Ceftazidime Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceftazidime Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceftazidime Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceftazidime Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Ceftazidime Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceftazidime Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceftazidime Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceftazidime Injection Sales by Country
  2. 10.1.1 South America Ceftazidime Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceftazidime Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Ceftazidime Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceftazidime Injection Market Size by Country
  6. 10.2.1 South America Ceftazidime Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceftazidime Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceftazidime Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceftazidime Injection Sales by Country
  2. 11.1.1 Middle East and Africa Ceftazidime Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceftazidime Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceftazidime Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceftazidime Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Ceftazidime Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceftazidime Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceftazidime Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceftazidime Injection Value Chain Analysis
  2. 12.1.1 Ceftazidime Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceftazidime Injection Production Mode & Process
  7. 12.2 Ceftazidime Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceftazidime Injection Distributors
  10. 12.2.3 Ceftazidime Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst